Purpose: To investigate the efficacy of combined use of retinal repetitive electromagnetic stimulation and subtenon autologous platelet-rich plasma in the treatment of recalcitrant or unresponsive chronic central serous chorioretinopathy.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The chronic CSCR cases included here meet one or more of the following criteria:
* Complaints of recurrent symptoms lasting longer than 3 months;
* Recalcitrant or unresponsive to all known current treatment modalities including PDT and MPL;
* Typical B-scan SD-OCT findings of chronicity such as elongation of photoreceptor outer segments indicating chronic nature of sub-macular fluid and/or the presence of serous flat-irregular RPED and focal areas of thickened RPE that lie below the collection of SRF;
* Widespread RPE/photoreceptor damage, RPE mottling and atrophy along with chronic submacular fluid;
* Widespread multifocal areas of chronic serous retinal detachment and/or flat-irregular RPEDs in those eyes that effective and reliable laser application is impossible.
Exclusion Criteria:
* Sub-threshold micro-pulse laser and/or photodynamic therapy applied in the last three months;
* Chronic CSCR complicated with secondary CNV.
What they're measuring
1
Sub-macular thickness
Timeframe: Change from baseline sub-macular thickness at 1 months